Tianfang Li Selected Research

Tianfang Li Research Topics

Disease

10	Neoplasms (Cancer) 03/2024 - 05/2006
4	AIDS-Related Complex (ARC) 11/2022 - 01/2014
3	Dermatomyositis (Dermatopolymyositis) 08/2023 - 06/2021
3	Pancreatic Neoplasms (Pancreatic Cancer) 08/2022 - 05/2019
2	Rheumatoid Arthritis 05/2024 - 08/2019
2	Breast Neoplasms (Breast Cancer) 08/2023 - 12/2006
2	Type 2 Diabetes Mellitus (MODY) 10/2022 - 01/2022
2	Lupus Nephritis 11/2019 - 01/2018
2	IGA Glomerulonephritis (IGA Nephropathy) 11/2016 - 10/2016
1	Infections 08/2023
1	Myositis (Idiopathic Inflammatory Myopathies) 08/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2023
1	Skin Ulcer 05/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2022
1	Non-alcoholic Fatty Liver Disease 10/2022
1	Arthrogryposis renal dysfunction cholestasis syndrome 06/2022
1	Myalgia 02/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Carotid Artery Diseases 01/2022
1	Atherosclerosis 01/2022
1	Fever (Fevers) 10/2021
1	Esophagitis 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 10/2020
1	Thrombotic Microangiopathies 10/2020
1	Nausea 08/2019
1	Vomiting 08/2019
1	Spinal Diseases (Disease, Spinal) 01/2018
1	Proteinuria 01/2018
1	Low Back Pain (Lumbago) 01/2018
1	Disease Progression 01/2018
1	Glomerulonephritis 10/2016
1	Neoplasm Metastasis (Metastasis) 12/2006
1	Prostatic Neoplasms (Prostate Cancer) 04/2006

Drug/Important Bio-Agent (IBA)

3	Methotrexate (Mexate)FDA LinkGeneric 05/2024 - 08/2019
3	Biomarkers (Surrogate Marker)IBA 08/2023 - 06/2021
3	GlucocorticoidsIBA 05/2023 - 01/2020
2	Sulfamethoxazole FDA LinkGeneric 05/2023 - 01/2023
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2023 - 01/2020
2	Indicators and Reagents (Reagents)IBA 10/2022 - 01/2018
2	Ferritins (Ferritin)IBA 02/2022 - 10/2021
2	Interleukin-8 (Interleukin 8)IBA 11/2016 - 10/2016
2	Secretory Immunoglobulin A (SIgA)IBA 11/2016 - 10/2016
1	tocilizumab (atlizumab)FDA Link 05/2024
1	SolutionsIBA 03/2024
1	Interleukin-10 (Interleukin 10)IBA 08/2023
1	LactoferrinIBA 08/2023
1	Blood Proteins (Serum Proteins)IBA 08/2023
1	Proteins (Proteins, Gene)FDA Link 08/2023
1	C-Reactive ProteinIBA 05/2023
1	Calcineurin InhibitorsIBA 05/2023
1	tofacitinibIBA 05/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2023
1	Therapeutic UsesIBA 01/2023
1	Calcium Carbonate (Limestone)FDA Link 01/2023
1	Trimethoprim (Proloprim)FDA LinkGeneric 01/2023
1	TabletsIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 10/2022
1	LipidsIBA 10/2022
1	HDL CholesterolIBA 10/2022
1	Triglycerides (Triacylglycerol)IBA 10/2022
1	Uric Acid (Urate)IBA 01/2022
1	Azathioprine (Imuran)FDA LinkGeneric 01/2020
1	AntibodiesIBA 01/2020
1	AutoantibodiesIBA 11/2019
1	Vitamin D FDA LinkGeneric 11/2019
1	Transaminases (Aminotransferases)IBA 08/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 08/2019
1	Leucovorin (Folinic Acid)FDA Link 08/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018
1	interleukin-21 (interleukin 21)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	CytokinesIBA 01/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2018
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2018
1	Immunoglobulin A (IgA)IBA 10/2016
1	Integrin alphaVbeta3IBA 12/2006
1	IntegrinsIBA 12/2006
1	Small Interfering RNA (siRNA)IBA 12/2006
1	Integrin alphaVIBA 12/2006
1	CobaltIBA 04/2006
1	Protons (Proton)IBA 04/2006

Therapy/Procedure

10	Radiotherapy 03/2024 - 05/2006
7	Therapeutics 05/2024 - 12/2006
4	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 09/2022 - 11/2013
1	Particle Accelerators 03/2024
1	Drug Therapy (Chemotherapy) 01/2023
1	Immunotherapy 01/2023
1	Stents 08/2022
1	Surgical Instruments (Clip) 05/2019
1	Proton Therapy 04/2006